The research, led by Laura de Cubas, Adrian Konopko, Susanna Boronat, José Ayté, and Elena Hidalgo, focused on the fission yeast Schizosaccharomyces pombe, a single-celled organism that has long served as an elegant model for understanding oxidative stress biology. In these cells, the dominant peroxiredoxin is an enzyme called Tpx1, which performs a remarkable dual duty. Under normal conditions, Tpx1 acts as a scavenger, keeping steady-state hydrogen peroxide concentrations below toxic thresholds through its peroxidase activity. But when peroxide levels rise beyond what the enzyme can neutralize, Tpx1 undergoes a functional transformation of sorts: it switches into a signaling mode, relaying the oxidative signal to Pap1, a transcription factor that orchestrates the activation of stress-defense genes. This relay mechanism, in which the peroxiredoxin effectively hands off oxidative information to its downstream partner, is conceptually similar to pathways found in mammalian cells, making the yeast findings broadly relevant to human biology.

The central difficulty in studying peroxiredoxins has always been their multitasking nature. Because Tpx1 simultaneously detoxifies hydrogen peroxide and activates Pap1, any experiment that removes or disables the enzyme eliminates both functions at once, making it impossible to determine which of its two roles produces which cellular outcome. Is the enzyme’s protective effect due purely to its scavenging, or does signaling through Pap1 contribute independently? Does activation of the transcription factor require direct physical contact between Tpx1 and Pap1 in the same cellular compartment, or is it the global lowering of peroxide levels that matters? To answer these questions, the Barcelona team turned to synthetic biology, designing a system in which the two functions could be experimentally disentangled and assigned to different molecules in different places.

The strategy was elegantly straightforward in concept. The researchers engineered yeast cells to express hydrogen peroxide-scavenging enzymes in specific subcellular compartments, comparing the native peroxiredoxin Tpx1 with catalase, encoded by the gene Ctt1, a mechanistically different peroxidase that breaks down hydrogen peroxide but cannot participate in the Tpx1–Pap1 signaling relay. By targeting these two scavengers to the cytosol, the mitochondria, and the nucleus, and then measuring both hydrogen peroxide concentrations and Pap1 activation with genetically encoded fluorescent biosensors, the team could assign cellular phenotypes to specific functions in specific locations. HyPer7, a highly sensitive fluorescent reporter of hydrogen peroxide, allowed the researchers to visualize peroxide dynamics in living cells with compartment-specific resolution, transforming a question that was previously intractable into one that could be answered quantitatively.

The first major finding concerned the protective role of peroxide scavenging. Cells lacking Tpx1 cannot survive in high-oxygen environments, a growth defect that has been a hallmark phenotype of peroxiredoxin studies. The researchers found that this defect could be rescued by catalase as well as by Tpx1, and that either enzyme could provide this protection from any of the subcellular compartments tested. In other words, the simple act of removing hydrogen peroxide, wherever it is performed, suffices to keep cells alive under aerobic stress. This result decisively established that detoxification is a spatially flexible function: the cell does not care which enzyme does the scavenging or where it does it, as long as the peroxide load is reduced.

The second major finding, however, revealed a striking contrast. While detoxification proved spatially promiscuous, redox signaling did not. Cells engineered to express Tpx1 exclusively in the mitochondria or exclusively in the nucleus were able to control hydrogen peroxide levels effectively, confirming that the peroxiredoxin is a highly efficient peroxidase regardless of its address within the cell. Yet these same cells displayed reduced tolerance to oxidative stress, and the reason was clear: activation of the transcription factor Pap1 required Tpx1 to be present in the cytosol. When cytosolic Tpx1 was absent, the signaling relay broke down, the stress-response program failed to engage properly, and cells became vulnerable even though their peroxide-scavenging capacity remained intact. The signaling function, unlike the scavenging function, is anchored to a specific cellular geography.

This asymmetry between the two functions carries significant conceptual weight for the field of redox biology. It demonstrates that peroxiredoxins are not merely peroxide drains but genuine transducers whose informational role depends on physical proximity to their signaling partners. The Tpx1–Pap1 system is a canonical example of a redox relay, in which oxidative modification of the peroxiredoxin is chemically transferred to the transcription factor, enabling Pap1 to accumulate in the nucleus and induce antioxidant genes. The new data indicate that this handoff is a local event that cannot be satisfied by equivalent peroxide removal elsewhere in the cell. A nuclear or mitochondrial peroxiredoxin may perfectly well keep hydrogen peroxide in check, but it cannot substitute for the cytosolic conversation between Tpx1 and Pap1.

The use of genetically encoded fluorescent H2O2 reporters deserves particular emphasis, because it represents a methodological advance that has reshaped how redox signaling is studied. Earlier generations of experiments relied on indirect measurements or dye-based probes that lacked compartmental specificity and suffered from artifacts. HyPer7 and related biosensors, by contrast, report peroxide concentrations in real time within defined organelles, permitting researchers to correlate local peroxide dynamics with functional outcomes such as transcription factor activation and cell survival. In the present study, the combination of compartment-targeted scavengers and compartment-targeted sensors allowed the authors to construct something like a spatial map of peroxide metabolism, revealing where in the cell the molecule is sensed, where it is destroyed, and where those two processes do and do not communicate with each other.

The implications extend well beyond yeast. Peroxiredoxins are among the most abundant proteins in many organisms, and the human genome encodes six Prx isoforms distributed among the cytosol, mitochondria, and other compartments. Human peroxiredoxins have been implicated in tumor progression, inflammatory signaling, neurodegeneration, and metabolic disease, and a longstanding question in the field is whether their pathological or protective roles stem from their peroxidase activity, their signaling function, or an interplay of both. The work by de Cubas and colleagues provides a conceptual framework for addressing this question: by manipulating the subcellular localization of individual Prx family members, researchers can in principle separate the detoxification and signaling contributions of each isoform in disease-relevant contexts. A mitochondrial peroxiredoxin that supports tumor cell survival, for instance, might be doing so primarily through scavenging, while a cytosolic isoform driving inflammatory gene expression might be acting chiefly as a redox transducer.

The study also speaks to an evolving appreciation of hydrogen peroxide itself as a spatially structured molecule rather than a homogeneous cellular entity. Because peroxide is membrane-permeable yet rapidly consumed by local enzymes, its concentration can differ substantially between the cytosol, nucleus, and mitochondria, and these gradients can themselves carry information. The Barcelona team’s finding that Tpx1 controls peroxide levels efficiently from any compartment, while catalase cannot, points to kinetic and functional differences between peroxidase classes that shape these gradients. Peroxiredoxins, with their high catalytic rates and sensitivity to peroxide-mediated inactivation, appear uniquely suited to act as both buffers and sensors at the subcellular scale, whereas catalases, though robust detoxifiers, lack the reactivity profile needed for signaling relays.

Funded by the Spanish Ministry of Science and Innovation, the Generalitat de Catalunya, and the European Regional Development Fund, and published open access under a Creative Commons license, the study reflects a maturing phase in redox biology, one in which the tools now exist to ask where, when, and how reactive oxygen species function as signals rather than simply whether they are harmful. The broader message is one of biological economy and precision: a single enzyme family has been repurposed by evolution to serve two masters, detoxification and information transfer, and the cell keeps these duties separate not through different chemistries but through the simple, elegant device of subcellular address. For a molecule as reactive and ephemeral as hydrogen peroxide, geography turns out to be destiny, and the peroxiredoxins, stationed at their specific posts throughout the cell, are the gatekeepers that decide whether peroxide becomes waste to be disposed of or a message to be delivered.

FOXO3, a member of the forkhead box O (FOXO) family of transcription factors, is widely recognized for its capacity to modulate a range of essential cellular processes such as oxidative stress response, DNA repair, apoptosis, and longevity. The study conducted by Huang et al. delineates a precise molecular interplay wherein FOXO3 activation prompts a cell cycle arrest that is essential for the regulation of ferroptosis, marking a significant advance in our understanding of how cells integrate stress signals to determine their fate.

The authors employed a rigorous combination of molecular biology techniques, including gene expression profiling, chromatin immunoprecipitation, and live-cell imaging, to elucidate the dynamics of FOXO3 activation under ferroptotic stress. Their data demonstrated that FOXO3, upon induction, activates a transcriptional program leading to the upregulation of cell cycle inhibitors, effectively pausing the cell cycle at G1/S or G2/M checkpoints. This cell cycle arrest appears to be a protective mechanism that governs the cellular iron metabolism machinery, thereby modulating susceptibility to lipid peroxidation and subsequent ferroptotic cell death.

One of the most compelling findings of this research is the revelation that FOXO3-mediated cell cycle arrest serves as a critical checkpoint preventing premature ferroptosis in vulnerable cells. By stabilizing iron homeostasis and orchestrating the detoxification of lipid peroxides, FOXO3 indirectly curtails the oxidative damage characteristic of ferroptosis. This insight challenges previously held notions that ferroptosis is solely a pathway triggered by uncontrolled iron-dependent oxidative stress, positioning FOXO3 as an essential modulator rather than a passive participant.

Moreover, the study found that perturbations in the FOXO3 pathway, either through genetic knockdown or pharmacological inhibition, result in heightened ferroptotic sensitivity. Cells deficient in FOXO3 failed to adequately enact cell cycle arrest, leading to exacerbated lipid peroxidation and accelerated death. Conversely, enforced expression of FOXO3 rescued cells from ferroptosis, affirming its role as a master regulator in this death pathway.

The implications of these findings transcend fundamental cell biology, potentially influencing therapeutic strategies in oncology and neuroprotection. In cancer, where ferroptosis induction is an emerging strategy to eliminate resistant tumor cells, modulation of FOXO3 activity could fine-tune cell cycle checkpoints to enhance the efficacy of ferroptotic stimuli. Conversely, in neurodegenerative diseases where excessive ferroptosis contributes to neuronal loss, promoting FOXO3 activation might preserve cell viability and function.

Importantly, the molecular circuitry delineated by Huang and colleagues sheds light on the cross-talk between cell cycle dynamics and metabolic pathways governing ferroptosis. FOXO3’s transcriptional targets include a suite of genes involved in iron storage, lipid metabolism, and antioxidant defense, creating a multifaceted shield against ferroptotic triggers. This integrative regulatory network exemplifies how transcription factors synchronize distinct cellular programs to maintain homeostasis under stress.

The research further illustrates that FOXO3’s regulation of cell cycle arrest is context-specific, influenced by the nature and intensity of cellular stressors. Under mild oxidative challenges, transient FOXO3 activation induces temporary quiescence, enabling repair and survival. However, under severe iron overload or lipid peroxidation, prolonged FOXO3 activity may shift the balance towards controlled ferroptosis, suggesting a dual role dependent on cellular milieu.

By harnessing sophisticated genetic models and ferroptosis-specific assays, the study confirms that FOXO3’s interaction with cell cycle components such as p21 and p27 is indispensable for its anti-ferroptotic function. The coordinated upregulation of these cyclin-dependent kinase inhibitors enforces the cell cycle blockade, underscoring the intertwined nature of proliferation control and cell death decisions.

Another intriguing aspect revealed is FOXO3’s modulation of mitochondrial function, which plays a critical role in cellular redox status and susceptibility to ferroptosis. FOXO3 activation promotes mitochondrial biogenesis and augments antioxidant capacity, mitigating the mitochondrial reactive oxygen species (ROS) that catalyze lipid peroxidation. This mitochondrial crosstalk further consolidates the multifaceted defense orchestrated by FOXO3.

The translational potential of this study is immense. The authors highlight the prospects of small molecules or gene therapy vectors designed to activate FOXO3 selectively in pathological contexts characterized by ferroptotic dysregulation. Such interventions could offer precision control over cell fate, shifting the balance between survival and death with therapeutic benefit.

Beyond disease, these insights contribute fundamentally to the cell death landscape by integrating cell cycle regulation with ferroptotic mechanisms, previously considered largely independent. This synthesis enriches our conceptual framework of cellular stress responses, paving the way for novel research avenues exploring interplay between cell proliferation, metabolic control, and programmed cell death.

In summation, Huang et al.’s elucidation of FOXO3-mediated cell cycle arrest as a gatekeeper of ferroptosis reveals a sophisticated and nuanced regulatory axis central to cellular homeostasis. The intricately choreographed transcriptional responses orchestrated by FOXO3 highlight its indispensable role in determining cell fate in the face of ferroptotic stress, offering promising new directions for therapeutic innovation.

As ferroptosis continues to gain prominence in the realms of pathology and therapy, understanding its regulation by factors like FOXO3 reshapes how we approach complex diseases linked to oxidative stress and iron metabolism. This study marks a significant milestone toward harnessing programmed cell death pathways for precise clinical interventions, reflecting the extraordinary plasticity and resilience of cellular systems.

Subject of Research: Regulation of ferroptosis through FOXO3-induced cell cycle arrest

Article Title: Activation of a FOXO3-induced cell cycle arrest regulates ferroptosis

Article References:
Huang, H., van Sligtenhorst, M., Smits, A.M.M. et al. Activation of a FOXO3-induced cell cycle arrest regulates ferroptosis. Cell Death Discov. 11, 465 (2025). https://doi.org/10.1038/s41420-025-02760-x

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41420-025-02760-x